DCF — ENCOMPASS HEALTH REHABILITATION HOSP
Enterprise Value: $25.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$25.7M
Enterprise Value
$6.7M
PV of Cash Flows
$19.0M
PV of Terminal Value
$30.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $36.2M | $3.4M | 9.0% | $1.2M | $1.1M |
| Year 2 | $37.3M | $3.9M | 10.0% | $1.6M | $1.3M |
| Year 3 | $38.4M | $4.4M | 11.0% | $1.9M | $1.4M |
| Year 4 | $39.5M | $4.7M | 12.0% | $2.1M | $1.4M |
| Year 5 | $40.7M | $4.9M | 12.0% | $2.2M | $1.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $25.7M. Terminal value accounts for 74% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$35.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.0890263024387488
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5